Literature DB >> 1826245

Unexplained deaths of type 1 diabetic patients.

R B Tattersall1, G V Gill.   

Abstract

The suggestion of an increase in the number of sudden deaths of young people with Type 1 diabetes in the UK has been investigated. It was suggested that such deaths were due to hypoglycaemia and related to the increasing use of human insulin. In total we were notified of 50 deaths of people with Type 1 diabetes under age 50 years in the UK in 1989 which our informants (relatives, physicians, and pathologists) considered sudden and unexpected. An autopsy had been done in all cases and we supplemented this with detailed clinical information from relatives and case records. Of the 50 cases we excluded five with a definite cause of death, 11 suicides or self-poisonings, six cases of ketoacidosis, and four in which there was insufficient information about the circumstances of death to drawn any conclusions. Of the other 24 cases, two patients had been found with irreversible hypoglycaemic brain damage and died after a period of artificial ventilation. The most puzzling group were 22, aged 12-43 years, most of whom had gone to bed in apparently good health and been found dead in the morning. Nineteen of the 22 were sleeping alone at the time of death and 20 were found lying in an undisturbed bed. Most had uncomplicated diabetes and in none were anatomical lesions found at autopsy. There are major difficulties in diagnosing hypoglycaemia post-mortem, but the timing of death and other circumstantial evidence suggests that hypoglycaemia or a hypoglycaemia-associated event was responsible. All patients were taking human insulin at the time of death but most had been changed from animal insulin between 6 months and 2 years earlier and there was nothing to implicate the species of insulin as a factor in these deaths.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1826245     DOI: 10.1111/j.1464-5491.1991.tb01516.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  66 in total

Review 1.  Severe hypoglycemia in adults.

Authors:  Mary F Carroll; Mark R Burge; David S Schade
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

2.  Human insulin and unawareness of hypoglycaemia: need for a large randomised trial.

Authors:  M Egger; G D Smith; A Teuscher
Journal:  BMJ       Date:  1992-08-08

Review 3.  Cardiovascular disease risk in young people with type 1 diabetes.

Authors:  Janet K Snell-Bergeon; Kristen Nadeau
Journal:  J Cardiovasc Transl Res       Date:  2012-04-12       Impact factor: 4.132

Review 4.  Hypoglycemia and Cardiovascular Disease: Lessons from Outcome Studies.

Authors:  Frank Pistrosch; Markolf Hanefeld
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

5.  Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway.

Authors:  T Skrivarhaug; H-J Bangstad; L C Stene; L Sandvik; K F Hanssen; G Joner
Journal:  Diabetologia       Date:  2005-12-20       Impact factor: 10.122

Review 6.  Clinical pharmacokinetics and pharmacodynamics of insulin aspart.

Authors:  A Lindholm; L V Jacobsen
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 7.  Aspects of Hyperglycemia Contribution to Arterial Stiffness and Cardiovascular Complications in Patients With Type 1 Diabetes.

Authors:  Daniel Gordin; Per-Henrik Groop
Journal:  J Diabetes Sci Technol       Date:  2016-08-22

Review 8.  Impact of hypoglycemia in hospitalized patients.

Authors:  Michelle Carey; Laura Boucai; Joel Zonszein
Journal:  Curr Diab Rep       Date:  2013-02       Impact factor: 4.810

Review 9.  Adverse effects of exogenous insulin. Clinical features, management and prevention.

Authors:  A W Patrick; G Williams
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

Review 10.  Hypoglycemia, diabetes, and cardiovascular events.

Authors:  Cyrus V Desouza; Geremia B Bolli; Vivian Fonseca
Journal:  Diabetes Care       Date:  2010-06       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.